BOEHRINGER INGELHEIM USA CORPORATION
WD
WILLIAM DENT
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC · Washington, DC
Registered · LDAActive
Background
Career
BI
Government experience
Director
Federal Government Affairs. Sen. Marshall, Rep. John Joyce, Sen. Tillis, Rep. Buddy Carter
Covered official positions, as disclosed on federal filings
The past 12 months
Clients
1
past 12 months
Filings
1
past 12 months
Agencies contacted
Agriculture, Dept of (USDA)Centers For Medicare and Medicaid Services (CMS)HOUSE OF REPRESENTATIVESSENATE
Specific issues
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025; H.R. 946/S. 1862, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals Education about cancer and Medicare screening coverage, including H.R. 842/S. 339, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Issues related to FY2026 Appropriations
Issues related to prescription drug pricing and value Prescription drug manufacturing and supply chains Issues related to 340B program Issues related to tax and tariffs Issues related to Intellectual Property Issues related to Inflation Reduction Act
Clients
Sources
This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗
Recent filings1
lda.gov →